首站-论文投稿智能助手
典型文献
Bergenin,a PPARγ agonist,inhibits Th17 differentiation and subsequent neutrophilic asthma by preventing GLS1-dependent glutaminolysis
文献摘要:
Bergenin is a natural PPARy agonist that can prevent neutrophil aggregation,and often be used in clinics for treating respiratory diseases.Recent data show that Th17 cells are important for neutrophil aggregation and asthma through secreting IL-17A.In this study,we investigated the effects of bergenin on Th17 differentiation in vitro and subsequent neutrophilic asthma in mice.Naive T cells isolated from mouse mesenteric lymph nodes were treated with IL-23,TGF-β,and IL-6 to induce Th17 differentiation.We showed that in naive T cells under Th17-polarizing condition,the addition of bergenin(3,10,30 μM)concentration-dependently decreased the percentage of CD4+IL-17A+T cells and mRNA expression of specific transcription factor RORyt,and function-related factors IL-17A/F,IL-21,and IL-22,but did not affect the cell vitality and apoptosis.Furthermore,bergenin treatment prevented GLS1-dependent glutaminolysis in the progress of Th17 differentiation,slightly affected the levels of SLC1A5,SLC38A1,GLUD1,GOT1,and GPT2.Glutamine deprivation,the addition of glutamate(1 mM),α-ketoglutarate(1 mM),or GLS1 plasmid all significantly attenuated the above-mentioned actions of bergenin.Besides,we demonstrated that bergenin(3,10,and 30 μM)concentration-dependently activated PPARy in naive T cells,whereas PPARy antagonist GW9662 and siPPARy abolished bergenin-caused inhibition on glutaminolysis and Th17 differentiation.Furthermore,we revealed that bergenin inhibited glutaminolysis by regulating the level of CDK1,phosphorylation and degradation of Cdh1,and APC/C-Cdh1-mediated ubiquitin-proteasomal degradation of GLS1 after activating PPARy.We demonstrated a correlation existing among bergenin-affected GLS1-dependent glutaminolysis,PPARγ,"CDK1-APC/C-Cdh1"signaling,and Th17 differentiation.Finally,the therapeutic effect and mechanisms for bergenin-inhibited Th17 responses and neutrophilic asthma were confirmed in a mouse model of neutrophilic asthma by administration of GW9662 or GLS1 overexpression plasmid in vivo.In conclusion,bergenin repressed Th17 differentiation and then alleviated neutrophilic asthma in mice by inhibiting GLS1-dependent glutaminolysis via regulating the"CDK1-APC/C-Cdh1"signaling after activating PPARγ.
文献关键词:
作者姓名:
Ling Yang;Yun Zheng;Yu-meng Miao;Wen-xin Yan;Yan-zhi Geng;Yue Dai;Zhi-feng Wei
作者机构:
Department of Pharmacology of Chinese Materia Medica,School of Traditional Chinese Pharmacy,China Pharmaceutical University,Nanjing 210009,China
引用格式:
[1]Ling Yang;Yun Zheng;Yu-meng Miao;Wen-xin Yan;Yan-zhi Geng;Yue Dai;Zhi-feng Wei-.Bergenin,a PPARγ agonist,inhibits Th17 differentiation and subsequent neutrophilic asthma by preventing GLS1-dependent glutaminolysis)[J].中国药理学报(英文版),2022(04):963-976
A类:
Bergenin,bergenin,17A+T,RORyt,SLC38A1,siPPARy
B类:
inhibits,Th17,differentiation,subsequent,neutrophilic,asthma,by,preventing,GLS1,glutaminolysis,natural,that,aggregation,often,clinics,treating,respiratory,diseases,Recent,data,cells,are,important,through,secreting,In,this,study,investigated,effects,vitro,mice,Naive,isolated,from,mouse,mesenteric,lymph,nodes,were,treated,TGF,induce,We,showed,naive,under,polarizing,condition,addition,concentration,dependently,decreased,percentage,CD4+IL,specific,transcription,function,related,factors,but,did,not,vitality,apoptosis,Furthermore,treatment,prevented,progress,slightly,affected,levels,SLC1A5,GLUD1,GOT1,GPT2,Glutamine,deprivation,glutamate,mM,ketoglutarate,plasmid,significantly,attenuated,above,mentioned,actions,Besides,demonstrated,activated,whereas,antagonist,GW9662,abolished,caused,inhibition,revealed,inhibited,regulating,CDK1,phosphorylation,degradation,Cdh1,APC,mediated,ubiquitin,proteasomal,after,activating,correlation,existing,among,signaling,Finally,therapeutic,mechanisms,responses,confirmed,model,administration,overexpression,vivo,conclusion,repressed,then,alleviated,inhibiting
AB值:
0.428974
相似文献
Romidepsin (FK228) improves the survival of allogeneic skin grafts through downregulating the production of donor-specific antibody via suppressing the IRE1 α-XBP1 pathway
Yuliang GUO;Siyu SONG;Xiaoxiao DU;Li TIAN;Man ZHANG;Hongmin ZHOU;Zhonghua Klaus CHEN;Sheng CHANG-Institute of Organ Transplantation,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Key Laboratory of Organ Transplantation,Ministry of Education,NHC Key Laboratory of Organ Transplantation,Key Laboratory of Organ Transplantation,Chinese Academy of Medical Sciences,Wuhan 430030,China;Henan Key Laboratory of Digestive Organ Transplantation,Open and Key Laboratory of Hepatobiliary&Pancreatic Surgery and Digestive Organ Transplantation at Henan Universities,Zhengzhou Key Laboratory of Hepatobiliary&Pancreatic Diseases and Organ Transplantation,Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;Department of Cardiothoracic and Vascular Surgery,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China
Globular adiponectin-mediated vascular remodeling by affecting the secretion of adventitial-derived tumor necrosis factor-αinduced by urotensin Ⅱ
Jun LI;Limin LUO;Yonggang ZHANG;Xiao DONG;Shuyi DANG;Xiaogang GUO;Wenhui DING-Department of Cardiology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Division of Cardiology,Department of Internal Medicine,Taihe Hospital,Hubei University of Medicine,Shiyan 442000,China;Division of Cardiology,Department of Internal Medicine,Peking University First Hospital,Beijing 100034,China;Department of Dermatology,the First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Cardiovascular Diseases,the Second Affiliated Hospital,Shantou University Medical College,Shantou 515041,China
Comparative study on the anti-tuberculous effect and mechanism of the traditional Chinese medicines NiuBeiXiaoHe extract and JieHeWan
Li-Yao Duan;Yan Liang;Wen-Ping Gong;Yong Xue;Jie Mi;Jie Wang;Lan Wang;Zai-Xing Jia;Hong Lei;Yu-Mei Liang;Jun Liu;Yue Zheng;Xue-Qiong Wu-Tuberculosis Prevention and Control Key Laboratory, Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Tuberculosis Research Institute, the 8th Medical Center,Chinese PLA General Hospital, Beijing 100091, China;Hebei North University, Zhangjiakou 075000, Hebei, China;Clinical Laboratory,the 8th Medical Center, Chinese PLA General Hospital, Beijing 100091,China;Pathology Department, the 8th Medical Center, Chinese PLA General Hospital, Beijing 100091, China;Guangdong Qifang Pharmaceutical Co., Ltd, Guangzhou 510075, China
Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion via integrin/ BRAF/TAK1/ERK/ETV4 signaling
Panpan Ma;Xinxin Jin;Zhiwei Fan;Zhou Wang;Suhui Yue;Changyue Wu;Shiyin Chen;Yuanyuan Wu;Miaomiao Chen;Donghua Gu;Siliang Zhang;Renfang Mao;Yihui Fan-Laboratory of Medical Science,School of Medicine,Nantong University,Nantong 226001,China;Department of Pathogenic Biology,School of Medicine,Nantong University,Nantong 226001,China;Department of Clinical Laboratory,Yancheng No.1 People's Hospital,Yancheng 224005,China;School of Life Sciences,Nantong University,Nantong 226001,China;Department of Dermatology,Affiliated Hospital of Nantong University,Nantong University,Nantong 226001,China;The Department of Urology,the Second Affiliated Hospital of Nantong University,Nantong University,Nantong 226001,China;The Department of Radiotherapy Oncology,Harbin Medical University Cancer Hospital,Harbin 150086,China;Department of Pathophysiology,School of Medicine,Nantong University,Nantong 226001,China
IL13Rα1 prevents a castration resistant phenotype of prostate cancer by targeting hexokinase 2 for ubiquitin-mediated degradation
Tingting Feng;Jing Wang;Kai Cheng;Qiqi Lu;Ru Zhao;Shiguan Wang;Qingyun Zhang;Luna Ge;Jihong Pan;Guanhua Song;Lin Wang-Department of Pathology,School of Basic Medical Sciences,Shandong University,Jinan 250012,China;Department of Pathology,The Fourth People's Hospital of Jinan,Jinan 250031,China;Department of PET-CT,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250002,China;The Second Hospital,Cheeloo College of Medicine,Shandong University Medical School,Jinan 250012,China;Biomedical Sciences College&Shandong Medicinal Biotechnology Centre,Key Lab for Biotech-Drugs of National Health Commission,Key Lab for Rare&Uncommon Diseases of Shandong Province,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Biochemistry and Molecular Biology,Shandong University School of Basic Medical Sciences,Jinan 250012,China;Institute of Basic Medicine,Shandong Academy of Medical Sciences,Shandong First Medical University&Shandong Academy of Medical Sciences,Jinan 250002,China;Department of Oncology,The First Affiliated Hospital of Shandong First Medical University,Jinan 250014,China
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
Leyi Yao;Qian Zhao;Ding Yan;Ziying Lei;Yali Hao;Jinghong Chen;Qian Xue;Xiaofen Li;Qingtian Huang;Daolin Tang;Q.Ping Dou;Xin Chen;Jinbao Liu-Affiliated Cancer Hospital&Institute of Guangzhou Medical University,Guangzhou 510095,China;Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation,State Key Laboratory of Respiratory Disease,School of Basic Medical Sciences,Guangzhou Medical University,Guangzhou 511436,China;Institute of Digestive Disease of Guangzhou Medical University,The Sixth Affiliated Hospital of Guangzhou Medical University,Qingyuan People's Hospital,Qingyuan 511518,China;School of Public Health,Guangzhou Medical University,Guangzhou,511436,China;Department of Surgery,UT Southwestern Medical Center,Dallas,TX 75390,USA;Barbara Ann Karmanos Cancer Institute and Departments of Oncology,Pharmacology&Pathology,School of Medicine,Wayne State University,Detroit,MI 48201,USA
Taxifolin attenuates inflammation via suppressing MAPK signal pathway in vitro and in silico analysis
Xingyan Zhang;Xiaoyan Lian;Huling Li;Wenjing Zhao;Xin Li;Fujun Zhou;Yutong Zhou;Tao Cui;Yuli Wang;Changxiao Liu-Key Laboratory of Quality-marker of Traditional Chinese Medicines,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Center for Drug Evaluation,National Medical Products Administration,Beijing 100022,China;Department of Pharmacology,Tianjin Medical University,Tianjin 300070,China;State Key Laboratory of Drug Delivery Technology and Pharmacokinetics,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Key Laboratory of Systems Bioengineering(Ministry of Education),School of Chemistry Engineering and Technology,Tianjin University,Tianjin 300072,China;Pharmaceuticai Armaceuticai DA REN TANG Group Corporation Limited Traditional Chinese Pharmacy Researchinstitute,Tianjin 300457,China;Tianjin Key Laboratory of Quality Control in Chinese Medicine,Tianjin 300457,China;Research Unit for Drug Metabolism,Chinese Academy of Medical Sciences,Beijing 100730,China
LncRNA DACH1 protects against pulmonary fibrosis by binding to SRSF1 to suppress CTNNB1 accumulation
Jian Sun;Tongzhu Jin;Zhihui Niu;Jiayu Guo;Yingying Guo;Ruoxuan Yang;Qianqian Wang;Huiying Gao;Yuhan Zhang;Tianyu Li;Wenxin He;Zhixin Li;Wenchao Ma;Wei Su;Liangliang Li;Xingxing Fan;Hongli Shan;Haihai Liang-Department of Pharmacology(State-Province Key Laboratories of Biomedicine-Pharmaceutics of China,Key Laboratory of Cardiovascular Research,Ministry of Education),College of Pharmacy,Harbin Medical University,Harbin 150081,China;Northern Translational Medicine Research and Cooperation Center,Heilongjiang Academy of Medical Sciences,Harbin Medical University,Harbin 150081,China;Zhuhai People's Hospital,Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment,Zhuhai Hospital Affiliated with Jinan University,Jinan University,Zhuhai 519000,China;Department of Thoracic Surgery,Shanghai Pulmonary Hospital,Tongji University,Shanghai 200433,China;State Key Laboratory of Quality Research in Chinese Medicine/Macau Institute for Applied Research in Medicine and Health,Macau University of Science and Technology,Macau(SAR),China;Research Unit of Noninfectious Chronic Diseases in Frigid Zone(2019RU070),Chinese Academy of Medical Sciences,Harbin 150081,China
Inhibition of ASCT2 induces hepatic stellate cell senescence with modified proinflammatory secretome through an IL-1α/NF-κB feedback pathway to inhibit liver fibrosis
Feixia Wang;Zhanghao Li;Li Chen;Ting Yang;Baoyu Liang;Zili Zhang;Jiangjuan Shao;Xuefen Xu;Guoping Yin;Shijun Wang;Hai Ding;Feng Zhang;Shizhong Zheng-Jiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica,School of Pharmacy,Nanjing University of Chinese Medicine,Nanjing 210023,China;Department of Anesthesiology,Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine,Nanjing 210003,China;College of Traditional Chinese Medicine,Shandong University of Traditional Chinese Medicine,Jinan 250035,China;Department of General Surgery,Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine,Nanjing 210003,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。